Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians DOI Creative Commons
Marisa Booty, Kathi L.H. Harp, Evan Batty

et al.

Journal of Substance Use and Addiction Treatment, Journal Year: 2023, Volume and Issue: 149, P. 209051 - 209051

Published: April 19, 2023

Language: Английский

Different forms of stigma and rural primary care professionals' willingness to prescribe buprenorphine DOI Creative Commons
Berkeley Franz, Lindsay Y. Dhanani,

Sean M. Bogart

et al.

Journal of Substance Use and Addiction Treatment, Journal Year: 2025, Volume and Issue: unknown, P. 209633 - 209633

Published: Jan. 1, 2025

Language: Английский

Citations

0

Pharmacy Harm Reduction Practices to Help Reduce Opioid Overdoses, Arizona 2023 DOI Creative Commons
Beth E. Meyerson,

Sergio Richter,

Ross Gordon

et al.

Journal of the American Pharmacists Association, Journal Year: 2025, Volume and Issue: unknown, P. 102348 - 102348

Published: Feb. 1, 2025

Characterizing pharmacies based on their practices, community need for such practices and pharmacy type could advance pharmacy-based intervention precision to reinforce or increase related reducing opioid overdose deaths. To measure a combination of 3 focused death reduction explore whether there are discernable groupings characteristics, characteristics. A telephone survey was conducted between August 1, 2023 October 8, with the pharmacist duty at 921 Arizona pharmacies. The measured buprenorphine stocking, naltrexone dispensing, likelihood methadone dispensing use disorder (OUD) when legally permitted, interest in state-subsidized naloxone dispensing. response rate 22.6% achieved (N = 208). vast majority (93.8%) stocked dispensed naltrexone. About half (47.6%) were very likely somewhat dispense OUD permitted. Metropolitan less compared rural (45.1% Vs. 75.0%). Among not methadone, 85.3% located counties rates above national average. indicated enrolling as distributor naloxone. When considered together 26% reported frequent expressed subsidized Latent class analysis yielded 4 distinct groups ranging from those only frequently adopters community. 'adopters' who naltrexone, had naloxone, would tended be metropolitan small/rural areas but mass merchandizers. An emerging group shows potential greater adoption reduce overdose. Larger, multistate studies will help verify latent practice interventions communities. It is crucial why higher adopt reduction.

Language: Английский

Citations

0

Enhancing Hepatitis C Management: Mortality Trends and Disparities in the US by Sex, Age Group, Race/Ethnicity and Region (1999–2020) DOI Open Access
Sophia Ahmed, Muhammad Asfandyar Nadir, Hanzala Ahmed Farooqi

et al.

Journal of Viral Hepatitis, Journal Year: 2025, Volume and Issue: 32(4)

Published: March 1, 2025

ABSTRACT Hepatitis C virus (HCV) infection affects approximately 3.9 million people in the United States (U.S.), leading to 8000 10,000 deaths annually. Despite advancements curative treatments since 2014, effective strategies targeting high‐risk groups are crucial. This study examines HCV‐related mortality trends from 1999 2020, focusing on demographic and regional disparities using CDC WONDER database. A retrospective analysis was conducted were identified International Classification of Diseases, Tenth Revision (ICD‐10) codes B17.1 B18.2. Mortality data categorised by gender, age, race/ethnicity, region, place death urbanisation status. We calculated crude rates (CRs) age‐adjusted (AAMRs) per 100,000 population. Joinpoint regression significant changes trends. total 324,008 reported. The overall AAMR 4.27 (95% Confidence Interval [CI]: 4.25 4.28). increased 2014 (1999 2007 Annual Percent Change [APC]: 5.00; APC: 1.95) declined sharply 2020 (APC: −7.11). Males exhibited higher (AAMR: 6.28) than females 2.42). 55–64 years age group had highest CR (16.38), while non‐Hispanic (NH) American Indians rate 8.72) among racial groups. Regionally, South (5.80), nearly double that West (2.23) Midwest (2.62). show variations. Targeted interventions essential reduce HCV burden, particularly vulnerable

Language: Английский

Citations

0

Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky DOI Creative Commons
Umedjon Ibragimov,

Katherine Cooper,

Evan Batty

et al.

Harm Reduction Journal, Journal Year: 2021, Volume and Issue: 18(1)

Published: June 30, 2021

Abstract Background Enrolling sufficient number of people who inject drugs (PWID) into syringe services programs (SSP) is important to curtail outbreaks drug-related harms. Still, little known about barriers and facilitators SSP enrollment in rural areas with no history such programs. This study’s purpose was develop a grounded theory the role risk environment individual characteristics PWID shaping Kentucky. Methods We conducted one-on-one semi-structured interviews 41 clients 5 SSPs that were established counties Appalachian Kentucky 2017–2018. Interviews covered needs, process becoming aware SSPs, enrollment. Applying constructivist methods guided by Intersectional Risk Environment Framework (IREF), we applied open, axial selective coding theory. Results Stigma, feature IREF’s meso-level social domain, main factor hampering hesitated visit because internalized stigma anticipated from police, friends, family healthcare providers. Fear often mitigated or amplified constellation environmental factors related (e.g., SSPs) (PWID networks) domains PWID’s characteristics. as barrier providing low threshold friendly atmosphere, offering their program IDs protect them paraphernalia charges. spread positive information within networks helped hesitant peers enroll accompanying SSPs. Individual characteristics, including child custody, employment high status, made certain more susceptible hence likely delay Conclusions Features environments operating at meso-level, well appear enhance mitigate effect opening locations against need ensure services, police mobilize promote

Language: Английский

Citations

25

Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians DOI Creative Commons
Marisa Booty, Kathi L.H. Harp, Evan Batty

et al.

Journal of Substance Use and Addiction Treatment, Journal Year: 2023, Volume and Issue: 149, P. 209051 - 209051

Published: April 19, 2023

Language: Английский

Citations

9